Status:
COMPLETED
Relationship Between Homocysteine and BMD
Lead Sponsor:
Fundación Santiago Dexeus Font
Conditions:
Postmenopausal Women
Eligibility:
FEMALE
50+ years
Brief Summary
The association between Homocysteine (Hcy) levels and bone mineral density (BMD) has been debated. Some studies have found a relationship between increased Hcy plasma levels and BMD in contrast; other...
Eligibility Criteria
Inclusion
- Postmenopausal women
- BMD measured by dual-energy X-ray absorptiometry (DXA)
Exclusion
- Primary ovarian failure
- Early menopause
- Cardiovascular, liver, or renal diseases
- Surgical menopause
- History of cancer
- Receiving treatment known to influence levels of Hcy or bone mineralization (folates or vitamin B12 supplements, menopausal hormonal treatment, corticosteroids, anticonvulsants, heparin, thiazide diuretics, and antiresorptive agents).
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
760 Patients enrolled
Trial Details
Trial ID
NCT04821492
Start Date
April 1 2019
End Date
March 31 2020
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Quiron Dexeus
Barcelona, Spain, 08028